United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 10, 2026 · Filed Apr 13, 2026

On Apr 10, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$569.28 for US$5.41M under a trading plan, leaving 40,513 shares. Filed Apr 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$569.28 average (US$567.24 to US$573.01)
Value
US$5.41M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 10, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 10, 2026Common StockSale442US$567.2449,571Direct
Apr 10, 2026Common StockSale2,105US$568.0047,466Direct
Apr 10, 2026Common StockSale3,183US$568.9744,283Direct
Apr 10, 2026Common StockSale2,056US$569.9742,227Direct
Apr 10, 2026Common StockSale1,215US$570.8841,012Direct
Apr 10, 2026Common StockSale459US$571.6840,553Direct
Apr 10, 2026Common StockSale40US$573.0140,513Direct

Source

View original at SEC

Related